Shilpa Medicare

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE790G01031
  • NSEID: SHILPAMED
  • BSEID: 530549
INR
422.00
2.85 (0.68%)
BSENSE

Apr 10

BSE+NSE Vol: 3.75 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 780523,
    "name": "Shilpa Medicare",
    "stock_name": "Shilpa Medicare",
    "full_name": "Shilpa Medicare Ltd",
    "name_url": "stocks-analysis/shilpa-medicare",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "422.00",
    "chg": 2.85,
    "chgp": "0.68%",
    "dir": 1,
    "prev_price": "419.15",
    "mcapval": "8,236.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 530549,
    "symbol": "SHILPAMED",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE790G01031",
    "curr_date": "Apr 10",
    "curr_time": "",
    "bse_nse_vol": "3.75 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 10, 2026",
    "traded_date_str": "2026 04 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shilpa-medicare-780523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Shilpa Medicare Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-3933753",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShilpaMedicareL_technicaldot_3933753.png",
        "date": "2026-04-06 08:01:51",
        "description": "Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for investors as the stock price advances to ₹388.00, up 3.69% on 6 Apr 2026."
      },
      {
        "title": "Shilpa Medicare Gains 11.09%: 3 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-gains-1109-3-key-factors-driving-the-weeks-rally-3932092",
        "imagepath": "",
        "date": "2026-04-04 16:00:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>30 Mar:</strong> Stock opens week at Rs.348.65 amid broad market weakness</p>\n                    <p><strong>1 Apr:</strong> Intraday high of Rs.376.20 with a 7.84% surge and strong gap up</p>\n                    <p><strong>2 Apr:</strong> Continued gains to Rs.388.75 supported by technical upgrades</p>\n                    <p><strong>3 Apr:</strong> MarketsMOJO upgrades rating to Hold reflecting improved fundamentals</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.348.65</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week ..."
      },
      {
        "title": "Shilpa Medicare Ltd Upgraded to Hold: A Detailed Analysis of Quality, Valuation, Financial Trend and Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-upgraded-to-hold-a-detailed-analysis-of-quality-valuation-financial-trend-and-technicals-3931268",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShilpaMedicareL_mojoScore_3931268.png",
        "date": "2026-04-03 08:10:16",
        "description": "Shilpa Medicare Ltd has seen its investment rating upgraded from Sell to Hold as of 2 April 2026, reflecting notable improvements across technical indicators, valuation metrics, and financial performance. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that have driven this change, providing investors with a detailed understanding of the company’s current standing within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Shilpa Medicare Ltd Surges 7.84% to Day's High of Rs 376.2 — Outperforms Sector by 5.77 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-hits-intraday-high-with-784-surge-on-1-april-2026-3928765",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShilpaMedicareL_priceRelatedfactors_3928765.png",
        "date": "2026-04-01 10:22:29",
        "description": "The Sensex advanced 2.49% on 1 Apr 2026, yet Shilpa Medicare Ltd outpaced the broader market with a 7.84% gain, reaching an intraday high of Rs 376.2. This 5.77-percentage-point outperformance over the Pharmaceuticals &amp; Biotechnology sector’s 2.07% rise signals a distinctly stock-specific surge rather than a mere market tailwind."
      },
      {
        "title": "Shilpa Medicare Ltd Opens 5.06% Higher Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-opens-strong-with-significant-gap-up-amid-positive-market-sentiment-3927924",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShilpaMedicareL_gapup_3927924.png",
        "date": "2026-04-01 09:33:59",
        "description": ""
      },
      {
        "title": "Shilpa Medicare Ltd Gains 8.11%: Key Technical Shifts and Market Moves This Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-gains-811-key-technical-shifts-and-market-moves-this-week-3921904",
        "imagepath": "",
        "date": "2026-03-28 14:04:39",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>23 Mar:</strong> Sharp decline of 3.54% amid broad market sell-off</p>\n                    <p><strong>24 Mar:</strong> Intraday high surge of 8.07%, closing at Rs.338.80</p>\n                    <p><strong>25 Mar:</strong> Continued gains with 2.01% rise to Rs.345.60</p>\n                    <p><strong>27 Mar:</strong> Mixed technical signals as stock closes at Rs.349.95 (+1.26%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.323.70</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.34..."
      },
      {
        "title": "Shilpa Medicare Ltd Shows Mixed Technical Signals Amid Sideways Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-shows-mixed-technical-signals-amid-sideways-momentum-shift-3918501",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ShilpaMedicareL_technicaldot_3918501.png",
        "date": "2026-03-27 08:02:08",
        "description": "Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish trend to a sideways stance. Despite a 2.01% gain on 27 Mar 2026, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes, reflecting cautious optimism amid sector headwinds."
      },
      {
        "title": "Shilpa Medicare Ltd Surges 8.07% to Day's High of Rs 333.7 — Outperforms Sector by 6.47 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-hits-intraday-high-with-807-surge-on-24-mar-2026-3910415",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ShilpaMedicareL_priceRelatedfactors_3910415.png",
        "date": "2026-03-24 12:01:01",
        "description": "The Sensex declined by 1.34% on 24 Mar 2026, while Shilpa Medicare Ltd surged 8.07%, outperforming its Pharmaceuticals &amp; Biotechnology sector by 6.47 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market environment."
      },
      {
        "title": "Shilpa Medicare Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-is-rated-sell-3905898",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ShilpaMedicareL_mojoScore_3905898.png",
        "date": "2026-03-23 10:10:16",
        "description": "Shilpa Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 385,
    "sid": "780523",
    "stock_news_url": "https://www.marketsmojo.com/news/shilpa-medicare-780523"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "09-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Shilpa Medicare Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L85110KA1987PLC008739</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>A+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>INDIA RATINGS AND RESEARCH PVT. LTD.</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: MS RITU TIWARY <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: CS@VBSHILPA.COM</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: MR ALPESH DALAL <br/> Designation: CFO <br/> EmailId: apleshdalal@vbshilpa.com</div> </div> <div> <br/> Date: 09/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Apr-2026",
      "details": "Submission of confirmation certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31 March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "Intimation of Closure of Trading Window under the SEBI (Prohibition of Insider Trading) Regulation 2015 for the fourth quarter and year ended 31 March 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shilpa Medicare Ltd has declared <strong>100%</strong> dividend, ex-date: 17 Sep 25",
          "dt": "2025-09-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shilpa Medicare Ltd has announced <strong>1:2</strong> stock split, ex-date: 06 Nov 15",
          "dt": "2015-11-06",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shilpa Medicare Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 03 Oct 25",
          "dt": "2025-10-03",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Shilpa Medicare Gains 11.09%: 3 Key Factors Driving the Week’s Rally

2026-04-04 16:00:03

Key Events This Week

30 Mar: Stock opens week at Rs.348.65 amid broad market weakness

1 Apr: Intraday high of Rs.376.20 with a 7.84% surge and strong gap up

2 Apr: Continued gains to Rs.388.75 supported by technical upgrades

3 Apr: MarketsMOJO upgrades rating to Hold reflecting improved fundamentals

Shilpa Medicare Ltd Gains 8.11%: Key Technical Shifts and Market Moves This Week

2026-03-28 14:04:39

Key Events This Week

23 Mar: Sharp decline of 3.54% amid broad market sell-off

24 Mar: Intraday high surge of 8.07%, closing at Rs.338.80

25 Mar: Continued gains with 2.01% rise to Rs.345.60

27 Mar: Mixed technical signals as stock closes at Rs.349.95 (+1.26%)

stock-recommendationAnnouncement

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

09-Apr-2026 | Source : BSE

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyShilpa Medicare Ltd
2CIN NO.L85110KA1987PLC008739
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 0.00
4Highest Credit Rating during the previous FY A+
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)INDIA RATINGS AND RESEARCH PVT. LTD.
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: MS RITU TIWARY
Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER
EmailId: CS@VBSHILPA.COM
Name of the Chief Financial Officer: MR ALPESH DALAL
Designation: CFO
EmailId: apleshdalal@vbshilpa.com

Date: 09/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

06-Apr-2026 | Source : BSE

Submission of confirmation certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31 March 2026.

Closure of Trading Window

25-Mar-2026 | Source : BSE

Intimation of Closure of Trading Window under the SEBI (Prohibition of Insider Trading) Regulation 2015 for the fourth quarter and year ended 31 March 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Shilpa Medicare Ltd has declared 100% dividend, ex-date: 17 Sep 25

stock-summary
SPLITS

Shilpa Medicare Ltd has announced 1:2 stock split, ex-date: 06 Nov 15

stock-summary
BONUS

Shilpa Medicare Ltd has announced 1:1 bonus issue, ex-date: 03 Oct 25

stock-summary
RIGHTS

No Rights history available